Dr Quah Song Chiek Daniel

Dr Daniel Quah is a Senior Consultant at the National Cancer Centre Singapore who has dual specialisation in both Radiation Oncology and Palliative Medicine. He lectures in various institution in the local education arena – teaching across the fraternities of medicine, nursing and allied health, and in both the undergraduate and post-graduate levels. He has a particularly strong interest in Boron Neutron Capture Therapy (BNCT), an emerging particle therapy technique that can deliver very high doses of radiation with minimal side effect, and has presented in several conferences on BNCT over the past few years. His other areas of interests include prognostication of patients with metastatic disease, multidisciplinary management of patients with spine metastases or cord compression, patient-determined outcomes and the care of adolescent and young adult oncology patients.

• FRCR (Clinical Oncology) 2010
• MBBS National University of Singapore 1997

• Senior Consultant, Department of Radiation Oncology, National Cancer Centre, Singapore, 2016 – Present
• Senior Consultant, Department of Supportive and Palliative Care, National Cancer Centre, Singapore, 2016 - Present
• Member, Chemotherapy Safety Committee, National Cancer Centre, Singapore, 2017-Present
• Member, Code Blue Committee, National Cancer Centre, Singapore, 2019- PresentConsultant, Department of Radiation Oncology, National Cancer Centre, Singapore, 2016 – Present

• ​EXSA Silver Award 2005

• ​​Validation of the Tokuhashi Score in this Era of Targeted Therapies, 2017- Ongoing
• Validation of The Palliative Prognostic Index, 2014-2015

• Boron neutron capture therapy in the treatment of lung cancer. Quah SC. J Xiangya Med 2018;3:29
• The Practice of Terminal Discharge – Is it Euthanasia by stealth? Murugam V, Quah SC, Krishnan L. Nurs Ethics. 2017 Jan
• Clinical potential of boron neutron capture therapy for locally recurrent inoperable previously irradiated head and neck cancer. Lim D, Quah DS, Leech M, Marignol L. Appl Radiat Isot. 2015 Dec;106:237-41.
• Concurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinoma. Tan T, Lim WT, Fong KW, Cheah SL, Soong YL, Ang MK, Ng QS, Tan D, Ong WS, Tan SH, Yip C, Quah D, Soo KC, Wee J. Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):952-60
• “Would you go broke to stay alive in Singapore?” – Further Analysis of a Survey on how costs may affect choice of therapy. Quah SC.  Am J Hosp Palliat Care. 2013 Sep;30(6):541-7